Form 4: Sanara MedTech Director James W. Stuckert Reports Acquisition of 3,440 Shares of Restricted Stock

Director James W. Stuckert reports acquiring 3,440 shares of restricted stock in Sanara MedTech Inc.

Summary

• On June 12, 2024, James W. Stuckert, a director of Sanara MedTech Inc. (SMTI), acquired 3,440 shares of common stock.
• These shares were granted as restricted stock under the company's 2014 Omnibus Long-Term Incentive Plan.
• The restricted stock will vest on June 12, 2025, contingent upon Mr. Stuckert's continued service to the company.
• Following the transaction, Mr. Stuckert directly owns 840,218 shares of common stock.
• He also indirectly owns 10,000 shares through the Diane V. Stuckert Revocable Trust, 46,500 shares through the James W. Stuckert Family Trust, and 70,254 shares through Ten Grand Ltd., where he serves as the general partner.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director suggests confidence in the company, but it's a routine transaction.

Positives

• The grant of restricted stock aligns Mr. Stuckert's interests with the long-term success of Sanara MedTech.
• Increased ownership demonstrates confidence in the company's future prospects.

Future Outlook

The vesting of the restricted stock is contingent upon the reporting person providing certain services to the Company through June 12, 2025.

Industry Context

This filing is a routine disclosure of stock ownership changes by a company insider, which is common in publicly traded companies. It provides transparency to investors regarding the holdings of key personnel.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider ownership.
• It aligns the director's interests with those of the shareholders.

Key Dates